Infectious disease test kit Covidiag

COVID-19diagnosticmultiparametric

Overview
Infectious diseases remain a major global health challenge. Rapid, multiplex serological analysis supports diagnosis, immune profiling and surveillance in clinical and laboratory settings. Covidiag and its companion solution Covidiag+ provide targeted multiplex detection of SARS-CoV-2 antibody responses to support assessment of immune status and cross-reactivity.

Covidiag & Covidiag+

• Covidiag simultaneously detects and differentiates five antibody targets against SARS-CoV-2 to enable comprehensive serological profiling.
• Covidiag+ expands the panel by including RBD domains from four SARS-CoV-2 variants (alpha, beta, gamma, delta and omicron) to evaluate cross-reactive responses.
• The inclusion of variant RBDs enables direct comparison of antibody response intensities between strains to support cross-immunity assessment.

Technical specifications

• Brand: Innobiochips
• Product name: Covidiag (with companion solution Covidiag+)
• Type: COVID-19 serological analysis kit / laboratory reagent
• Detection capability: simultaneous detection and identification of 5 SARS-CoV-2 antibodies
• Variant coverage (Covidiag+): alpha, beta, gamma, delta, omicron
• Feature: inclusion of RBD domains from 4 SARS-CoV-2 variants to compare antibody response intensities
• Sample type: human serum and plasma
• Intended use: laboratory serological analysis (clinical and research laboratories)

Clinical applications

• Serological immune profiling and antibody response characterization
• Evaluation of vaccine-induced and infection-induced antibody responses
• Seroepidemiological surveillance and cohort studies
• Assessment of cross-immunity across SARS-CoV-2 variants

Ordering and compatibility

• Delivered with companion Covidiag+ option for extended variant profiling
• Compatible with standard laboratory serological workflows; contact Innobiochips for protocol and instrument integration